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Abstract. Since the identification of species Porcine circovirus 2, the relevance of genus 19 
Circovirus has increased given its impact on the swine industry. A new species (Porcine 20 
circovirus 3, PCV-3) has been detected in association with various clinical conditions. 21 
Consequently, there is an urgent need for reliable and widely accessible tests for both routine 22 
diagnostic and research purposes. We developed a direct PCR (requiring no DNA extraction) and 23 
a quantitative (q)PCR targeting the conserved rep gene to detect the PCV-3 genome. Test 24 
performance was assessed by testing 120 field samples within different matrices. Both methods 25 
were sensitive (detection of 10 viral genome/µL), specific, and repeatable. The substantially 26 
perfect agreement between the 2 assays strongly supports their high sensitivity and specificity. 27 
The low cost and short processing time of the direct PCR protocol, together with the reliable 28 
quantitative results provided by qPCR, support the establishment of common testing guidelines. 29 
 30 
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Introduction 33 
Members of the Circoviridae family in the Circovirus genus are nonenveloped, icosahedral DNA 34 
viruses with a single-stranded circular genome of ~1.8–2 kb. Until the beginning of the 1990s, 35 
the relevance of this genus was limited to avian species, including species Beak and feather 36 
disease virus (BFDV), Pigeon circovirus (PiCV), and Goose circovirus (GoCV), which are 37 
responsible for clinically relevant diseases.30 More recently, circoviruses have been proven to 38 
infect several host species belonging to different animal classes. However, their causative role in 39 
overt clinical disease is still unclear in most instances.6 A remarkable exception is represented by 40 
species Porcine circovirus 2 (PCV-2), which has been identified as one of the major threats in 41 
the swine industry.27 Several studies performed over time have demonstrated viral evolution 42 
capabilites14 and high genetic diversity, particularly of the capsid gene.5,13 Such fast evolution is 43 
likely the result of natural immunity and vaccine-induced selective pressures.15 44 
In 2016, a new porcine circovirus species (Porcine circovirus 3, PCV-3) was detected in 45 
the United States,23,24 followed by detection in China,33 Europe,29 and Korea,20 leading to the 46 
hypothesis of worldwide distribution. Despite low identity with PCV-2 at both the nucleotide and 47 
amino acid (aa) levels, PCV-3 appears to share a similar genome organization. To date, 3 open 48 
reading frames (ORFs) have been identified in its genome. ORF1 putatively encodes a 297-aa 49 
protein highly related to Circoviridae replicase (rep). ORF2 is located in the viral 50 
complementary strand in opposite sense from the rep gene and encodes a 214-aa capsid (cap) 51 
protein. The function of ORF3, which is related to murid herpesvirus M169 (of species Murid 52 
betaherpesvirus 1), is still unknown.23 53 
PCV-3 has been detected in pigs suffering from several clinical syndromes, including 54 
porcine dermatitis and nephropathy syndrome, reproductive disorders, respiratory disease,19,23,28 55 
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and myocarditis.24 The presence of PCV-3 genome and/or antigen has been documented by 56 
several authors within histologic lesions in diseased animals, in the absence of other pathogens,23 57 
thus pointing to a potential role in several clinical conditions. PCV-3 has been detected in several 58 
tissues,24,33 serum,29 and semen.19 Moreover, it has been detected in the reproductive tract and in 59 
aborted fetuses.33 60 
Circulation of PCV-3 has also been reported in asymptomatic animals,33 and definitive 61 
confirmation of its etiologic role is still lacking. Similarly, little, if any, information is available 62 
about PCV-3 epidemiology, the relevance of co-factors, the dynamics of viral infection, or 63 
disease pathogenesis. 64 
Given the current paucity of data, and because of biologic, genomic, and epidemiologic 65 
similarities with PCV-2, it is important to validate rapid, reliable, and cost-effective tests that 66 
could be implemented both for diagnostic and research purposes. We describe herein the 67 
development and analytic validation of 2 PCR-based assays for detection of PCV-3: a direct PCR 68 
and a quantitative (q)PCR assay. A collection of field samples within different matrices was used 69 
to explore the performance of the assays. 70 
Materials and methods 71 
Positive control 72 
Because PCV-3 sequences but no isolates were available, the full genome of PCV-3 (kindly 73 
provided by Dr. B. Hause, Kansas State University, Manhattan, KS) was chemically synthesized 74 
(GenScript Biotech, Piscataway, NJ) and cloned in a pUC57-Kan plasmid. Chemically 75 
competent Escherichia coli (One Shot TOP10, Thermo Fisher Scientific, Waltham, MA) were 76 
then transformed and selected by growth in a kanamycin-enriched lysogeny broth culture 77 
medium. Successful transformation and plasmid insertion were confirmed by single-colony DNA 78 
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amplification and sequencing using the M13F (5’-GTAAAACGACGGCCAGT-3’) and M13R 79 
(5’-GCGGATAACAATTTCACACAGG-3’) primers, flanking the insertion site. Plasmid DNA 80 
was purified (QIAprep spin miniprep kit, Qiagen, Hilden, Germany). Additionally, potential 81 
residual bacterial genome contamination was removed by performing agarose gel 82 
electrophoresis, excising the specific DNA fragment, and purifying it (QIAquick gel extraction 83 
kit, Qiagen). The plasmid DNA was quantified (Qubit instrument, Thermo Fisher Scientific). 84 
The number of viral copies (i.e., plasmid) per µL was then calculated (DNA Copy Number and 85 
Dilution Calculator tool, https://goo.gl/ANXpex). 86 
Development and optimization of the direct PCR assay 87 
Several primer pairs were designed using Primer3Plus31 to cover a region of ~500 bp located in 88 
the PCV-3 rep region. PCR was performed (Phire animal tissue direct PCR kit, Thermo Fisher 89 
Scientific). To evaluate assay performance, various thermal protocols and reagent concentrations 90 
were attempted and compared by testing a 10-fold plasmid dilution (108–1 copy/µL). In order to 91 
simulate an actual clinical matrix, the dilution was performed on swine lung homogenate (10 mL 92 
of phosphate-buffered saline [PBS]/g of tissue) that had previously tested negative for PCV-3 93 
using all assays under development. However, given the impossibility of obtaining undeniably 94 
PCV-3–negative tissue and to prevent the risk that a low titer infection could artificially inflate 95 
the assay’s analytic sensitivity, a dilution curve was also performed on horse lung. The assay 96 
limit of detection (LOD, defined as the lowest viral amount that can be detected in at least 50% 97 
of replicates) and the absence of nonspecific amplification products were selected as criteria to 98 
evaluate and compare different assay settings. To test the effect of different matrices on assay 99 
performance, the same approach was used to validate the methods on swine serum and oral fluid. 100 
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Given that DNA extraction was not required for the direct PCR kit, the PCR was 101 
developed and optimized using the selected matrices directly as templates. 102 
Reactions were performed (2720 thermal cycler, Applied Biosystems, Foster City, CA), 103 
and amplification and specificity of the bands were visualized (Gel Doc XR system, Bio‐ Rad, 104 
Hercules, CA) after electrophoresis on 2% agarose gel and staining (EuroSafe nucleic acid 105 
staining solution, EuroClone, Pero, Italy). 106 
Development and optimization of the qPCR assay 107 
A comparable approach was used for qPCR development with minor modifications. Both 108 
primers and probes were designed based on the rep gene using Primer3Plus.31 Additionally, a 109 
commercially available exogenous internal control (IC; i.e., a region of the enhanced green 110 
fluorescent protein in a standard cloning vector) was also implemented in the qPCR validation.18 111 
To minimize the interference between the IC and viral target amplification, different IC plasmid 112 
and primer–probe combinations were evaluated to maximize PCV-3 detection sensitivity while 113 
consistently detecting IC, particularly at low PCV-3 titers. 114 
The assay LOD, efficiency, and coefficient of determination (R2), which were calculated 115 
using a serial 10-fold dilution curve, were selected as criteria to evaluate and compare different 116 
assay settings. qPCR efficiency (E) was evaluated through the formula E = 10(−1/slope) − 1. Slope 117 
was obtained through the calculation of linear regression between crossing points (Cq) and 118 
corresponding log-transformed viral titers. R2 summarizes the goodness-of-regression line fit in 119 
explaining the relationship between dilution and Cq. Unlike direct PCR, qPCR requires purified 120 
DNA as template. Thus, the plasmid dilution curve in lung homogenate, serum, and oral fluid 121 
was extracted (ExtractSpin TS kit, BIOLAB, Gorizia, Italy) before further processing. qPCR was 122 
performed (DyNamo ColorFlash probe qPCR kit, Thermo Fisher Scientific; LightCycler nano 123 
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instrument, Roche Diagnostic, Indianapolis, IN), and raw data were analyzed (LightCycler nano 124 
software v.1.1, Roche). 125 
Analytical validation 126 
After assay optimization, LOD and repeatability were evaluated in both assays; E and R2 were 127 
assessed in the qPCR only. A standard curve range of 108–1 copy/µL was built for each 128 
evaluated matrix (lung homogenate, serum, oral fluid), as described previously, and tested by 129 
both assays. The LOD was assessed by testing 10 times the standard curve lowest detected 130 
dilution. Repeatability was assessed by testing 6 replicates of 3 viral dilutions (107, 104, 101) in 3 131 
independent runs. For qPCR, the effect of dilution, replicate, and PCR run on Cq values was 132 
assessed using a repeated measures general linear model (GLM) as described previously.7,12 133 
Additionally, the coefficient of variation (CV) was calculated for different experiment levels 134 
(i.e., run and dilution) and matrices. For both assays, the agreement among qualitative results 135 
(i.e., positive or negative) of different PCR runs was evaluated using the Cohen kappa 136 
coefficient.4 Assay specificity was evaluated using a panel of several swine DNA pathogens, 137 
including PCV-1, PCV-2, Mycoplasma hyopneumoniae, porcine parvovirus 1 (PPV-1; species 138 
Ungulate protoparvovirus 1), PPV-2, Actinobacillus pleuropneumoniae, Trueperella pyogenes, 139 
and Bordetella bronchiseptica. 140 
Test sensitivity 141 
A total of 120 samples, originating from 55 farms located in Northern Italy and delivered to the 142 
Veterinary Infectious Disease (Dept. Animal Medicine, Production and Health, Padua 143 
University, Italy) laboratory for routine diagnostic purposes, were randomly selected for 144 
evaluation of test sensitivity. In particular, 39 lungs, 33 sera, 32 organ pools, 9 oral fluids, 3 145 
nasal swabs, and 4 environmental samples (i.e., sponges collected from trucks after sanitation) 146 
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were included in our analysis. Tissues were mechanically homogenized in PBS (10 mL of PBS/g 147 
of tissue) before further processing. Similarly, swabs and sponges were diluted in 500 µL of PBS 148 
and vortexed. DNA was extracted from 200 µL of liquid matrices (ExtractSpin TS kit, 149 
BIOLAB), setting the final elution volume to 100 µL. All samples were tested using the 150 
optimized direct PCR and qPCR protocols. The performance of the 2 methods was compared and 151 
their agreement evaluated using the Cohen kappa coefficient.4 152 
Results 153 
Direct PCR protocol 154 
The PCR optimization phase led to the definition of the following protocol: samples were 155 
pretreated by adding 2 µL of serum, oral fluid, or tissue homogenate to 20 µL of dilution buffer 156 
with 0.5 µL of DNARelease additive (Thermo Fisher Scientific). The solution was incubated for 157 
5 min at 25°C followed by 4 min at 98°C. Two µL of the solution was then added to a standard 158 
PCR master mix composed of 1× Phire animal tissue PCR buffer, 0.6 µM of each primer (Table 159 
1), and 0.4 µL of Phire hot start II DNA polymerase. Sterile NANOpure water (Thermo Fisher 160 
Scientific) was added to bring the final volume to 20 µL. The PCR thermic protocol was 98°C 161 
for 5 min followed by 45 cycles of 98°C for 5 s, 68°C for 7 s, and 72°C for 15 s. A final 162 
elongation step of 1 min at 72°C was performed. 163 
qPCR protocol 164 
The qPCR protocol was defined as follows: 2 µL of extracted DNA was added to a standard mix 165 
composed of 1× DyNAmo flash probe qPCR master mix (Thermo Fisher Scientific), 0.6 µM and 166 
0.3 µM of PCV-3–specific primers and probe, respectively (Table 1), 0.4 µM and 0.2 µM of IC 167 
primers and probe, respectively (Table 1), and 5 pg of IC plasmid. Sterile NANOpure water was 168 
added to bring the final volume to 10 µL. The cycling parameters were 95°C for 7 min, followed 169 
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by 45 cycles of 95°C for 10 s and 60°C for 30 s. The fluorescence signal was acquired at the end 170 
of each cycle extension phase. 171 
Analytic validation 172 
The viral genome was detected in the dilution range of 108–101 copies/µL by both assays and in 173 
all matrices examined (Fig. 1). The efficiency of the qPCR was 106.2% (slope = 3.18), with an 174 
error of 0.370 and R2 of 0.998 for the lung homogenate (fully comparable results were obtained 175 
independently of the matrix used for dilution preparation [i.e., swine or horse lung homogenate]), 176 
90.9% (slope = 3.56), with an error of 0.226 and R2 of 0.992 for the serum, and 93.6% (slope = 177 
3.48), with an error of 0.289 and R2 of 0.998 for the oral fluid. 178 
The repeatability of both assays was perfect (κ = 1) for all of the evaluated dilutions and 179 
matrices, with all replicates detected in all PCR runs. The GLM analysis, implemented to assess 180 
the repeatability of the qPCR quantitative results, revealed substantial equality of the standard 181 
curves, with only the effect of dilution being statistically significant (p < 0.05). No effect of the 182 
replicates of the PCR run and their interaction was detected at the set significance level (Fig. 2). 183 
The CV calculated for all experimental levels was constantly <0.06 (Table 2), further supporting 184 
the repeatability of the assay. Slightly higher, but still low CV (i.e., CV < 0.09) values were 185 
observed when different matrices were compared. The reaction efficiency that was calculated 186 
during repeatability evaluation was constantly close to 100%. 187 
Nonspecific amplification was not detected with either direct PCR or qPCR when other 188 
pathogens were tested. The IC was consistently detected with a Cq of ~30. However, a higher 189 
and more variable IC Cq occurred at a very high viral concentration (i.e., >107 copies/µL). 190 
Test sensitivity 191 
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Using the direct PCR and the qPCR assays, 41 and 42 of 120 samples tested positive for PCV-3, 192 
respectively. The agreement between the 2 assays was almost perfect (κ = 0.98; 95% confidence 193 
interval = 0.95–1%). Only one lung sample showed discordant results, negative to the direct PCR 194 
but positive to qPCR assay (estimated viral titer: 0.11 viral copies/µL). 195 
All tested matrices displayed at least one positive sample (Table 3). Even if oral fluids, 196 
lungs, and organ pools had higher viral titers (Fig. 3), the difference, evaluated using the 197 
Kruskal–Wallis rank sum test, was not statistically significant (data not shown). 198 
Discussion 199 
Both direct PCR and qPCR assays demonstrated excellent sensitivity, being able to detect as few 200 
as 10 viral copies/µL. The perfect qualitative repeatability demonstrated by both direct PCR and 201 
qPCR indicates they are of equivalent value, evidence further supported by the validation results. 202 
Unfortunately, it was not possible to compare the newly developed methods with a defined “gold 203 
standard” given that no reference method has yet been defined. However, the substantially 204 
perfect agreement of the 2 methods across the field samples strongly indicates their high 205 
sensitivity and specificity. Remarkably, the only discordant sample was a lung sample that was 206 
characterized by an extremely low estimated viral titer, using qPCR, and not detected with direct 207 
PCR. Consequently, the direct PCR method LOD could have been reached. Additionally, 208 
because this assay is based on the direct testing of 2 µL of target sample, the effect of stochastic 209 
sampling of viral particles and/or tissue pieces could be exacerbated compared with the qPCR 210 
assay, including a DNA extraction phase from 200 µL of sample. The high quantitative 211 
repeatability of the qPCR was demonstrated by the absence of any effect observed across 212 
replicates or experiment runs and by the very low CV within and between runs at each plasmid 213 
concentration. This feature, coupled with the almost perfect E, low error, and linearity of the Cq–214 
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titer relationship, provides a good basis for the use of qPCR in viral quantification, making it 215 
suitable for both diagnostic and research purposes. 216 
The capability of detecting minimal viral amounts is of great relevance from an 217 
epidemiologic perspective, because it allows accurate monitoring of viral circulation in 218 
subclinical scenarios. Similar considerations apply to several research fields, such as 219 
pathogenesis or control measure efficacy evaluation research,32 in which precise quantification of 220 
small viral titers can be fundamental. Moreover, qPCR can provide useful additional information 221 
compared to non-quantitative PCR techniques. Pathogen titer quantification is fundamental for 222 
the study of disease pathogenesis, virulence, tropism, epidemiology, and for the evaluation of 223 
control strategy efficacy (e.g., vaccination). As demonstrated for PCV-2,3,22 the potential 224 
relationship between viral titer and clinical signs cannot be underestimated and is of 225 
extraordinary importance in multifactorial diseases to differentiate clinical and subclinical 226 
infections. If this scenario was also confirmed for PCV-3,33 the presence of a validated method, 227 
shared among laboratories, would be the best approach to provide consistent and reliable 228 
quantitative results and, thus, define common guidelines.16 229 
Fully comparable results were obtained during the analytic validation process for all 230 
evaluated matrices, supporting the broad applicability of the validated methods to various 231 
matrices. Moreover, all matrices tested in the diagnostic validation step gave at least one PCV-3–232 
positive sample, confirming the applicability of both methods over a broad substrate range. Five 233 
of the 9 oral fluids considered herein were positive for PCV-3 DNA, thus suggesting the efficient 234 
shedding of this virus through oral secretions and the potential application of ropes as a sensitive 235 
tool for the monitoring of PCV-3 circulation at the herd level. Finally, the PCV-3 genome was 236 
also detected in environmental samples collected to check the efficacy of routine sanitation 237 
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procedures in removing pathogens (i.e., porcine reproductive and respiratory virus) from trucks 238 
after animal transportation (data not shown). 239 
Considering that PCV-3 is a single-stranded DNA virus, a group typically featuring a 240 
high substitution rate,9,13 both assays were designed to specifically target the rep gene. This 241 
region, encoding for protein(s) fundamental for viral replication, is in all likelihood subjected to 242 
strong purifying pressure, which should, as already reported for PCV-2,14,15 limit its diversity and 243 
heterogeneity. Accordingly, the comparison of primers and probes in both assays with the PCV-3 244 
genome demonstrated only one mismatch with the available sequences (data not shown). 245 
Although mismatches can potentially affect assay sensitivity and quantification accuracy, 246 
previous studies have demonstrated the robustness of qPCR when a low number of mismatches 247 
is present, particularly if the primer region rather than the probe region is affected.8 Even if 248 
available data are still scarce, the sequences used originated from different regions of the world 249 
(i.e. United States, China, Korea, and Europe) and, similarly to the situation with PCV-2,10,14 it is 250 
highly likely that PCV-3 has been circulating undetected for a long time in the swine population. 251 
Based on this information, PCV-3 genomes considered herein are likely representative of global 252 
PCV-3 genetic heterogeneity, thus supporting worldwide applicability of the 2 developed 253 
methods. Moreover, the targeted genome region was proven to be variable enough to prevent 254 
nonspecific interaction with other swine pathogens (particularly other circoviruses and single-255 
stranded DNA viruses) and to provide, if sequenced, useful information for the genetic 256 
characterization of the detected strains. 257 
A limited number of qPCR assays have been published for the detection of PCV-3.23,32 258 
However, the first reported assay23 lacks relevant measurement of analytic and diagnostic 259 
performance, given that the purpose of that study was to report a new infectious agent rather than 260 
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the validation of a test method. Besides a 10-fold higher sensitivity compared to others,32 our 261 
method differs because of the incorporation of an IC system. Target loss during extraction or the 262 
presence of PCR reaction inhibitors during amplification often causes low test sensitivity. 263 
Validation of an endogenous IC has some disadvantages, particularly because of the difficulty in 264 
selecting a gene constantly expressed in different tissues and clinical conditions. To overcome 265 
this problem, we included an exogenous IC directly in the qPCR master mix. The integration of a 266 
full-process IC (e.g., by spiking the IC plasmid in the template before extraction) would require 267 
only minimal efforts to determine the proper IC amount. At the established reaction conditions, 268 
the IC was consistently detected in all matrices, particularly at low viral concentrations, which 269 
are the samples most affected by inhibition or poor extraction efficiency. The successful 270 
implementation of a reliable IC represents an additional guarantee against false-negative results 271 
caused by PCR inhibitors or DNA loss during the extraction phase, increasing assay reliability. 272 
All previously described assays23,32 require DNA extraction. In contrast, the direct PCR 273 
described herein provides a rapid, highly automatable, and very economical approach to PCV-3 274 
detection. This technique could have wide application in high-throughput laboratories, in which 275 
time efficiency and cost reduction are of primary relevance. 276 
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Table 1. Primer and probes used for detection of porcine circovirus 3. 362 
Primer/probe Oligonucleotide Assay 
PCV3_rep_F 5’-AAAGCCCGAAACACAGGTGGTGT-3’ Direct PCR 
PCV3_rep_R 5’-TTTTCCCGCATCCTGGAGGACCAAT-3’  
PCV3_353_F 5’-TGACGGAGACGTCGGGAAAT-3’ qPCR 
PCV3_465_R 5’-CGGTTTACCCAACCCCATCA-3’  
PCV3_418_probe 5’-FAM-GGGCGGGGTTTGCGTGATTT-BHQ1-3’  
EGFP-1-F 5’-GACCACTACCAGCAGAACAC-3’ Hoffmann et al. (2006)18 (IC) 
EGFP-2-R 5’-GAACTCCAGCAGGACCATG-3’  
EGFP-Hex 5’-Hex-AGCACCCAGTCCGCCCTGAGCA-BHQ1-3’  
EGFP = enhanced green fluorescent protein. 363 
364 
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Table 2. Results of the repeatability performances for quantitative (q)PCR assays. Data are 365 
summarized in terms of mean ± standard deviation (SD) and coefficient of variation (CV) for 366 
each PCR run and evaluated matrix. Cumulative statistics (i.e., mean ± SD and CV) are also 367 
reported for each plasmid concentration, aggregating the results of all PCR runs. 368 
 
Lung Oral fluid Serum Total 
Mean SD CV Mean SD CV Mean SD CV Mean SD CV 
101             
Total 33.03 0.47 0.01 34.66 1.20 0.03 34.08 1.06 0.03 33.92 1.16 0.03 
1 33.11 0.48 0.01 34.52 1.82 0.05 34.89 1.18 0.03 34.17 1.44 0.04 
2 32.99 0.38 0.01 34.52 1.00 0.03 33.62 0.86 0.03 33.71 0.98 0.03 
3 32.98 0.478 0.01 34.93 0.64 0.02 33.73 0.70 0.02 33.88 1.01 0.03 
104             
Total 22.77 0.14 0.01 24.35 0.10 0.00 23.90 0.16 0.01 23.67 0.68 0.03 
1 22.82 0.21 0.01 24.41 0.05 0.00 24.08 0.12 0.00 23.77 0.72 0.03 
2 22.70 0.10 0.00 24.32 0.13 0.00 23.81 0.09 0.00 23.61 0.70 0.03 
3 22.80 0.08 0.00 24.33 0.08 0.00 23.81 0.09 0.00 23.65 0.66 0.03 
107             
Total 12.75 0.51 0.04 14.48 0.13 0.01 15.26 0.11 0.01 14.16 1.10 0.08 
1 12.69 0.43 0.03 14.56 0.07 0.00 15.21 0.08 0.00 14.15 1.12 0.08 
2 12.98 0.72 0.05 14.45 0.14 0.01 15.28 0.12 0.01 14.24 1.06 0.07 
3 12.58 0.32 0.02 14.42 0.13 0.01 15.28 0.12 0.01 14.10 1.18 0.08 
 369 
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Table 3. Summary of the qualitative results of quantitative (q)PCR for different matrices. The 371 
number of lungs testing negative or positive by direct PCR is reported in parentheses (remainder 372 
of direct PCR results are the same as those of the real-time qPCR). 373 
Matrix Negative Positive Total 
Oral fluids 4 5 9 
Lungs 23 (24) 16 (15) 39 
Organ pools 20 12 32 
Sera 28 5 33 
Sponges 2 2 4 
Nasal swabs 1 2 3 
Total 78 42 120 
 374 
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Figure 1. The results of a porcine circovirus 3 (PCV-3) genome 10-fold dilution range of 108–10 376 
copies/µL tested using the quantitative PCR for different matrices. The regression lines 377 
between Cq and corresponding viral titer are also displayed. 378 
Figure 2. Regression lines depicting the relationship between 3 points of the standard curve (i.e., 379 
viral titers 107, 104, and 101 copies/µL) and the corresponding Cq, evaluated by testing each 380 
sample 6 times on 3 independent quantitative PCR runs. Single replicates (points) and the 381 
regression lines have been color coded according to the specific PCR run. 382 
Figure 3. Boxplot reporting the porcine circovirus 3 (PCV-3) viral titer distribution in different 383 
matrices. The number of positive samples for each matrix is reported below the respective 384 
labels. 385 



